New Science Ventures

New Science Ventures is a venture capital firm that focuses on investments in life sciences and information technology companies. They invest in early and late stage companies taking novel scientific approaches to address significant unmet needs, while creating order-of-magnitude improvements in performances. The company also invests in companies using science-based innovations to address market needs in life sciences such as pharmaceuticals, biologics, medical devices, diagnostics, and IT. The team of the company expertise in strategy and corporate planning, operations and cost management, and leadership development.

New Science Ventures, established in 2004 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Private Equity, Seed investments across Developer Tools, Software, 3D Technology, Semiconductor, Hardware, Developer APIs, Technical Support, Manufacturing, Field-Programmable Gate Array (FPGA), Venture Capital. The organization boasts a portfolio of 81 investments, with an average round size of $25.1M and 18 successful exits. Their recent investments include Achronix Semiconductor, Easton Capital, Battery Ventures, Entrepia Ventures, BioVex. The highest investment round they participated in was $155.5B. Among their most notable exits are Achronix Semiconductor and Easton Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.